Virax Biolabs Group Ltd [NASDAQ: VRAX] traded at a high on Friday, posting a 1.87 gain after which it closed the day’ session at $2.18.
The results of the trading session contributed to over 264274 shares changing hands. Over the past one week, the price volatility of Virax Biolabs Group Ltd stands at 15.83% while the volatility over the past one month is 20.88%.
The market cap for VRAX stock reached $9.46 million, with 4.34 million shares outstanding and 4.05 million shares in the current float. Compared to the average trading volume of 1.88M shares, VRAX reached a trading volume of 264274 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Virax Biolabs Group Ltd [VRAX]?
The Average True Range (ATR) for Virax Biolabs Group Ltd is set at 0.36, with the Price to Sales ratio for VRAX stock in the period of the last 12 months amounting to 118.27. The Price to Book ratio for the last quarter was 0.65, with the Price to Cash per share for the same quarter was set at 1.68.
How has VRAX stock performed recently?
Virax Biolabs Group Ltd [VRAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.92. With this latest performance, VRAX shares gained by 41.56% in over the last four-week period, additionally plugging by 89.57% over the last 6 months – not to mention a rise of 107.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VRAX stock in for the last two-week period is set at 50.47, with the RSI for the last a single of trading hit 48.55, and the three-weeks RSI is set at 50.93 for Virax Biolabs Group Ltd [VRAX]. The present Moving Average for the last 50 days of trading for this stock 2.02, while it was recorded at 2.21 for the last single week of trading, and 1.78 for the last 200 days.
Virax Biolabs Group Ltd [VRAX]: Deeper insight into the fundamentals
Virax Biolabs Group Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.40 and a Current Ratio set at 11.58.
Insider trade positions for Virax Biolabs Group Ltd [VRAX]
The top three institutional holders of VRAX stocks are: VIRTU FINANCIAL LLC with ownership of 28058.0 shares, which is approximately 1.3984%. HRT FINANCIAL LP, holding 25672.0 shares of the stock with an approximate value of $$29000.0 in VRAX stocks shares; and HRT FINANCIAL LP, currently with $$12761.0 in VRAX stock with ownership which is approximately 0.5483%.
